Canada Life’s Voyager Therapeutics VYGR Stock Holding History

Canada Life’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,458	Closed	-$7K	–	2586
2021 Q1	$7K	Hold	1,458	–	–	﹤0.01%	2570
2020 Q4	$10K	Hold	1,458	–	–	﹤0.01%	2594
2020 Q3	$16K	Hold	1,458	–	–	﹤0.01%	2482
2020 Q2	$18K	Hold	1,458	–	–	﹤0.01%	2514
2020 Q1	$13K	Hold	1,458	–	–	﹤0.01%	2462
2019 Q4	$20K	Buy	+1,458	New	+$21.2K	﹤0.01%	2503
2019 Q3	–	Sell	-2,747	Closed	-$75K	–	2265
2019 Q2	$75K	Buy	2,747 +1,080	+65%	+$24.7K	﹤0.01%	2315
2019 Q1	$32K	Hold	1,667	–	–	﹤0.01%	2326
2018 Q4	$15K	Hold	1,667	–	–	﹤0.01%	2557
2018 Q3	$32K	Hold	1,667	–	–	﹤0.01%	2467
2018 Q2	$33K	Hold	1,667	–	–	﹤0.01%	2472
2018 Q1	$31K	Hold	1,667	–	–	﹤0.01%	2458
2017 Q4	$28K	Buy	+1,667	New	+$28.6K	﹤0.01%	2464

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Canada Life's VYGR Position: Q2 2021 in Review

Canada Life sold out of Voyager Therapeutics (VYGR) in Q2 2021, closing a stake of 1,458 shares — an estimated $7K sold.

Canada Life first reported a position in VYGR in Q4 2017 and held it in 13 quarters. The position peaked at $75K in Q2 2019. 78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

Canada Life reported no remaining Voyager Therapeutics position as of Q2 2021 after selling out during the quarter.
Canada Life sold 1,458 Voyager Therapeutics shares in Q2 2021, an estimated $7K.
Canada Life first reported a position in Voyager Therapeutics in Q4 2017 and held it in 13 quarters.
Canada Life's Voyager Therapeutics position peaked at $75K in Q2 2019.
78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on Canada Life's 13F filing for Q2 2021, filed 11 Aug 2021.